Listed

Incannex Healthcare Inc.

IXHLNasdaqCIK 1873875HealthcareFiscal year ends Jun 30

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2025
Operating income−$5.2m, Q4 FY2026
Net income−$2.5m, Q4 FY2026
Incannex Healthcare Inc., income statement, quarterly
Line itemUnitperiod not labelled2023-09-30Q2 FY20232023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reported0.1Revenue, Q1 FY2025, three months to 2024-09-30$74.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure0.0Revenue, Q2 FY2025, three months to 2024-12-31$12.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-15, accession 0001213900-25-043682. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-25, accession 0001628280-26-063506. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reported
Research and development$m2.6Research and development, period not labelled, three months to 2023-09-30$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure2.6Research and development, Q2 FY2023, three months to 2023-12-31$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure3.3Research and development, Q3 FY2024, three months to 2024-03-31$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001213900-25-043682.Report this figure4.4Research and development, Q4 FY2024, three months to 2024-06-30$4.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-09-29, accession 0001213900-25-092837. Derived: 12-month figure less the 9-month figure.Report this figure2.9Research and development, Q1 FY2025, three months to 2024-09-30$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure1.4Research and development, Q2 FY2025, three months to 2024-12-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure2.7Research and development, Q3 FY2025, three months to 2025-03-31$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure3.7Research and development, Q4 FY2025, three months to 2025-06-30$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-09-25, accession 0001628280-26-063506. Derived: 12-month figure less the 9-month figure.Report this figure1.1Research and development, Q1 FY2026, three months to 2025-09-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure2.3Research and development, Q2 FY2026, three months to 2025-12-31$2.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure0.3Research and development, Q3 FY2026, three months to 2026-03-31$321.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure1.5Research and development, Q4 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-09-25, accession 0001628280-26-063506. Derived: 12-month figure less the 9-month figure.Report this figure
Operating income$m(4.9)Operating income, period not labelled, three months to 2023-09-30−$4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure(8.0)Operating income, Q2 FY2023, three months to 2023-12-31−$8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure(7.4)Operating income, Q3 FY2024, three months to 2024-03-31−$7.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001213900-25-043682.Report this figure(9.7)Operating income, Q4 FY2024, three months to 2024-06-30−$9.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-09-29, accession 0001213900-25-092837. Derived: 12-month figure less the 9-month figure.Report this figure(6.3)Operating income, Q1 FY2025, three months to 2024-09-30−$6.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure(5.0)Operating income, Q2 FY2025, three months to 2024-12-31−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure(5.0)Operating income, Q3 FY2025, three months to 2025-03-31−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure(7.5)Operating income, Q4 FY2025, three months to 2025-06-30−$7.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-25, accession 0001628280-26-063506. Derived: 12-month figure less the 9-month figure.Report this figure(6.8)Operating income, Q1 FY2026, three months to 2025-09-30−$6.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure(7.0)Operating income, Q2 FY2026, three months to 2025-12-31−$7.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure(4.0)Operating income, Q3 FY2026, three months to 2026-03-31−$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure(5.2)Operating income, Q4 FY2026, three months to 2026-06-30−$5.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-25, accession 0001628280-26-063506. Derived: 12-month figure less the 9-month figure.Report this figure
Interest expense$mnot reportednot reportednot reportednot reported(0.0)Interest expense, Q1 FY2025, three months to 2024-09-30−$28.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure(0.0)Interest expense, Q2 FY2025, three months to 2024-12-31−$28.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure0.1Interest expense, Q3 FY2025, three months to 2025-03-31$132.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-15, accession 0001213900-25-043682.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-09-25, accession 0001628280-26-063506. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Interest expense, Q1 FY2026, three months to 2025-09-30−$5.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure(0.0)Interest expense, Q2 FY2026, three months to 2025-12-31−$5.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figurenot reportednot reported
Net income$m(0.7)Net income, period not labelled, three months to 2023-09-30−$726.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure(5.2)Net income, Q2 FY2023, three months to 2023-12-31−$5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure(6.0)Net income, Q3 FY2024, three months to 2024-03-31−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001213900-25-043682.Report this figure(6.5)Net income, Q4 FY2024, three months to 2024-06-30−$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-09-29, accession 0001213900-25-092837. Derived: 12-month figure less the 9-month figure.Report this figure(5.4)Net income, Q1 FY2025, three months to 2024-09-30−$5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure(5.9)Net income, Q2 FY2025, three months to 2024-12-31−$5.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure(4.0)Net income, Q3 FY2025, three months to 2025-03-31−$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure(31.6)Net income, Q4 FY2025, three months to 2025-06-30−$31.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-25, accession 0001628280-26-063506. Derived: 12-month figure less the 9-month figure.Report this figure(6.4)Net income, Q1 FY2026, three months to 2025-09-30−$6.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure(6.5)Net income, Q2 FY2026, three months to 2025-12-31−$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure(3.9)Net income, Q3 FY2026, three months to 2026-03-31−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure(2.5)Net income, Q4 FY2026, three months to 2026-06-30−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-25, accession 0001628280-26-063506. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share(0.08)Diluted EPS, period not labelled, three months to 2023-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure(0.33)Diluted EPS, Q2 FY2023, three months to 2023-12-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure(0.38)Diluted EPS, Q3 FY2024, three months to 2024-03-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001213900-25-043682.Report this figurenot reported(0.29)Diluted EPS, Q1 FY2025, three months to 2024-09-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure(0.33)Diluted EPS, Q2 FY2025, three months to 2024-12-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure(6.19)Diluted EPS, Q3 FY2025, three months to 2025-03-31−$6.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figurenot reported(0.02)Diluted EPS, Q1 FY2026, three months to 2025-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure(0.02)Diluted EPS, Q2 FY2026, three months to 2025-12-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure(0.35)Diluted EPS, Q3 FY2026, three months to 2026-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figurenot reported
Basic EPS$ per share(0.08)Basic EPS, period not labelled, three months to 2023-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure(0.33)Basic EPS, Q2 FY2023, three months to 2023-12-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure(0.38)Basic EPS, Q3 FY2024, three months to 2024-03-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001213900-25-043682.Report this figurenot reported(0.29)Basic EPS, Q1 FY2025, three months to 2024-09-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure(0.33)Basic EPS, Q2 FY2025, three months to 2024-12-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure(6.19)Basic EPS, Q3 FY2025, three months to 2025-03-31−$6.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figurenot reported(0.02)Basic EPS, Q1 FY2026, three months to 2025-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure(0.02)Basic EPS, Q2 FY2026, three months to 2025-12-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure(0.35)Basic EPS, Q3 FY2026, three months to 2026-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figurenot reported

Balance sheet

Cash and equivalents$67.7m, FY2026
Long-term debt$2.4m, Q2 FY2025
Shareholders' equity$67.4m, FY2026
Incannex Healthcare Inc., balance sheet, quarterly
Line itemUnitperiod not labelled2023-09-30Q2 FY20232023-12-31Q3 FY20242024-03-31FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31FY20262026-06-30
Cash and equivalents$mnot reported14.6Cash and equivalents, Q2 FY2023, at 2023-12-31$14.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-14, accession 0001213900-24-013611.Report this figure9.3Cash and equivalents, Q3 FY2024, at 2024-03-31$9.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001213900-24-043391.Report this figure5.9Cash and equivalents, FY2024, at 2024-06-30$5.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-09-29, accession 0001213900-25-092837.Report this figure3.6Cash and equivalents, Q1 FY2025, at 2024-09-30$3.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure2.1Cash and equivalents, Q2 FY2025, at 2024-12-31$2.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure6.7Cash and equivalents, Q3 FY2025, at 2025-03-31$6.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001213900-25-043682.Report this figure15.0Cash and equivalents, FY2025, at 2025-06-30$15.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure73.3Cash and equivalents, Q1 FY2026, at 2025-09-30$73.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure68.9Cash and equivalents, Q2 FY2026, at 2025-12-31$68.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure74.5Cash and equivalents, Q3 FY2026, at 2026-03-31$74.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure67.7Cash and equivalents, FY2026, at 2026-06-30$67.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure
Current assets$mnot reported21.3Current assets, Q2 FY2023, at 2023-12-31$21.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-14, accession 0001213900-24-013611.Report this figure16.3Current assets, Q3 FY2024, at 2024-03-31$16.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001213900-24-043391.Report this figure16.2Current assets, FY2024, at 2024-06-30$16.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-09-29, accession 0001213900-25-092837.Report this figure15.2Current assets, Q1 FY2025, at 2024-09-30$15.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure10.5Current assets, Q2 FY2025, at 2024-12-31$10.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure15.6Current assets, Q3 FY2025, at 2025-03-31$15.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001213900-25-043682.Report this figure20.0Current assets, FY2025, at 2025-06-30$20.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure78.3Current assets, Q1 FY2026, at 2025-09-30$78.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure74.7Current assets, Q2 FY2026, at 2025-12-31$74.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure80.1Current assets, Q3 FY2026, at 2026-03-31$80.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure72.8Current assets, FY2026, at 2026-06-30$72.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure
Total assets$mnot reported22.4Total assets, Q2 FY2023, at 2023-12-31$22.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-14, accession 0001213900-24-013611.Report this figure17.3Total assets, Q3 FY2024, at 2024-03-31$17.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001213900-24-043391.Report this figure17.0Total assets, FY2024, at 2024-06-30$17.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-09-29, accession 0001213900-25-092837.Report this figure16.0Total assets, Q1 FY2025, at 2024-09-30$16.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure11.1Total assets, Q2 FY2025, at 2024-12-31$11.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure16.2Total assets, Q3 FY2025, at 2025-03-31$16.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001213900-25-043682.Report this figure20.4Total assets, FY2025, at 2025-06-30$20.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure78.7Total assets, Q1 FY2026, at 2025-09-30$78.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure75.0Total assets, Q2 FY2026, at 2025-12-31$75.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure80.3Total assets, Q3 FY2026, at 2026-03-31$80.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure73.0Total assets, FY2026, at 2026-06-30$73.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure
Current liabilities$mnot reported3.2Current liabilities, Q2 FY2023, at 2023-12-31$3.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-14, accession 0001213900-24-013611.Report this figure2.9Current liabilities, Q3 FY2024, at 2024-03-31$2.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001213900-24-043391.Report this figure5.6Current liabilities, FY2024, at 2024-06-30$5.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-09-29, accession 0001213900-25-092837.Report this figure9.2Current liabilities, Q1 FY2025, at 2024-09-30$9.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure5.8Current liabilities, Q2 FY2025, at 2024-12-31$5.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure7.4Current liabilities, Q3 FY2025, at 2025-03-31$7.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001213900-25-043682.Report this figure7.0Current liabilities, FY2025, at 2025-06-30$7.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure1.6Current liabilities, Q1 FY2026, at 2025-09-30$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure1.5Current liabilities, Q2 FY2026, at 2025-12-31$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure1.9Current liabilities, Q3 FY2026, at 2026-03-31$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure1.5Current liabilities, FY2026, at 2026-06-30$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure
Total liabilities$mnot reported3.5Total liabilities, Q2 FY2023, at 2023-12-31$3.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-14, accession 0001213900-24-013611.Report this figure3.1Total liabilities, Q3 FY2024, at 2024-03-31$3.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001213900-24-043391.Report this figure5.8Total liabilities, FY2024, at 2024-06-30$5.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-09-29, accession 0001213900-25-092837.Report this figure9.5Total liabilities, Q1 FY2025, at 2024-09-30$9.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure10.1Total liabilities, Q2 FY2025, at 2024-12-31$10.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure8.8Total liabilities, Q3 FY2025, at 2025-03-31$8.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001213900-25-043682.Report this figure7.1Total liabilities, FY2025, at 2025-06-30$7.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure1.7Total liabilities, Q1 FY2026, at 2025-09-30$1.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure1.6Total liabilities, Q2 FY2026, at 2025-12-31$1.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure5.0Total liabilities, Q3 FY2026, at 2026-03-31$5.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure5.6Total liabilities, FY2026, at 2026-06-30$5.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reported2.4Long-term debt, Q2 FY2025, at 2024-12-31$2.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Short-term borrowings$mnot reportednot reportednot reportednot reportednot reported1.4Short-term borrowings, Q2 FY2025, at 2024-12-31$1.4m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure1.4Short-term borrowings, Q3 FY2025, at 2025-03-31$1.4m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-05-15, accession 0001213900-25-043682.Report this figurenot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m19.8Shareholders' equity, period not labelled, at 2023-09-30$19.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure18.9Shareholders' equity, Q2 FY2023, at 2023-12-31$18.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure14.1Shareholders' equity, Q3 FY2024, at 2024-03-31$14.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-15, accession 0001213900-24-043391.Report this figure11.2Shareholders' equity, FY2024, at 2024-06-30$11.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure6.6Shareholders' equity, Q1 FY2025, at 2024-09-30$6.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure1.0Shareholders' equity, Q2 FY2025, at 2024-12-31$964.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure7.4Shareholders' equity, Q3 FY2025, at 2025-03-31$7.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure13.4Shareholders' equity, FY2025, at 2025-06-30$13.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure77.0Shareholders' equity, Q1 FY2026, at 2025-09-30$77.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure73.4Shareholders' equity, Q2 FY2026, at 2025-12-31$73.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure75.2Shareholders' equity, Q3 FY2026, at 2026-03-31$75.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure67.4Shareholders' equity, FY2026, at 2026-06-30$67.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure

Cash flow

Operating cash flow$3.4m, Q4 FY2026
Capital expenditure−$1.0k, Q4 FY2026
Share repurchases$7.1m, Q4 FY2026
Incannex Healthcare Inc., cash flow, quarterly
Line itemUnitperiod not labelled2023-09-30Q2 FY20232023-12-31Q3 FY20242024-03-31Q4 FY20242024-06-30Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30
Operating cash flow$k(5,749)Operating cash flow, period not labelled, three months to 2023-09-30−$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure(2,103)Operating cash flow, Q2 FY2023, three months to 2023-12-31−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-14, accession 0001213900-25-013783. Derived: 6-month figure less the 3-month figure.Report this figure(4,351)Operating cash flow, Q3 FY2024, three months to 2024-03-31−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001213900-25-043682. Derived: 9-month figure less the 6-month figure.Report this figure(3,642)Operating cash flow, Q4 FY2024, three months to 2024-06-30−$3.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-09-29, accession 0001213900-25-092837. Derived: 12-month figure less the 9-month figure.Report this figure(2,245)Operating cash flow, Q1 FY2025, three months to 2024-09-30−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure(5,627)Operating cash flow, Q2 FY2025, three months to 2024-12-31−$5.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-13, accession 0001213900-26-015867. Derived: 6-month figure less the 3-month figure.Report this figure(3,159)Operating cash flow, Q3 FY2025, three months to 2025-03-31−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001213900-26-057227. Derived: 9-month figure less the 6-month figure.Report this figure(1,482)Operating cash flow, Q4 FY2025, three months to 2025-06-30−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-25, accession 0001628280-26-063506. Derived: 12-month figure less the 9-month figure.Report this figure(9,163)Operating cash flow, Q1 FY2026, three months to 2025-09-30−$9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure(4,622)Operating cash flow, Q2 FY2026, three months to 2025-12-31−$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-13, accession 0001213900-26-015867. Derived: 6-month figure less the 3-month figure.Report this figure(2,456)Operating cash flow, Q3 FY2026, three months to 2026-03-31−$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001213900-26-057227. Derived: 9-month figure less the 6-month figure.Report this figure3,374Operating cash flow, Q4 FY2026, three months to 2026-06-30$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-25, accession 0001628280-26-063506. Derived: 12-month figure less the 9-month figure.Report this figure
Capital expenditure$k221Capital expenditure, period not labelled, three months to 2023-09-30$221.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure59.0Capital expenditure, Q2 FY2023, three months to 2023-12-31$59.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-02-14, accession 0001213900-25-013783. Derived: 6-month figure less the 3-month figure.Report this figure(6.0)Capital expenditure, Q3 FY2024, three months to 2024-03-31−$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0001213900-25-043682. Derived: 9-month figure less the 6-month figure.Report this figure3.0Capital expenditure, Q4 FY2024, three months to 2024-06-30$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-09-29, accession 0001213900-25-092837. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001213900-26-057227. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-25, accession 0001628280-26-063506. Derived: 12-month figure less the 9-month figure.Report this figure2.0Capital expenditure, Q1 FY2026, three months to 2025-09-30$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure4.0Capital expenditure, Q2 FY2026, three months to 2025-12-31$4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-13, accession 0001213900-26-015867. Derived: 6-month figure less the 3-month figure.Report this figure5.0Capital expenditure, Q3 FY2026, three months to 2026-03-31$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001213900-26-057227. Derived: 9-month figure less the 6-month figure.Report this figure(1.0)Capital expenditure, Q4 FY2026, three months to 2026-06-30−$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-25, accession 0001628280-26-063506. Derived: 12-month figure less the 9-month figure.Report this figure
Share repurchases$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported1,138Share repurchases, Q3 FY2026, three months to 2026-03-31$1.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-15, accession 0001213900-26-057227. Derived: 9-month figure less the 6-month figure.Report this figure7,080Share repurchases, Q4 FY2026, three months to 2026-06-30$7.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-09-25, accession 0001628280-26-063506. Derived: 12-month figure less the 9-month figure.Report this figure

Shares

Diluted shares (weighted)12.35m, Q3 FY2026
Incannex Healthcare Inc., shares, quarterly
Line itemUnitperiod not labelled2022-12-31period not labelled2023-03-31period not labelled2023-09-30Q2 FY20232023-12-31Q3 FY20242024-03-31Q1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31
Diluted shares (weighted)m shares15.4Diluted shares (weighted), period not labelled, three months to 2022-12-3115,398,367 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-14, accession 0001213900-24-013611.Report this figure15.9Diluted shares (weighted), period not labelled, three months to 2023-03-3115,873,113 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001213900-24-043391.Report this figure15.9Diluted shares (weighted), period not labelled, three months to 2023-09-3015,873,113 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001213900-24-098421.Report this figure15.9Diluted shares (weighted), Q2 FY2023, three months to 2023-12-3115,873,113 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-14, accession 0001213900-25-013783.Report this figure15.9Diluted shares (weighted), Q3 FY2024, three months to 2024-03-3115,873,113 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001213900-25-043682.Report this figure17.6Diluted shares (weighted), Q1 FY2025, three months to 2024-09-3017,642,832 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure17.6Diluted shares (weighted), Q2 FY2025, three months to 2024-12-3117,624,422 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure0.7Diluted shares (weighted), Q3 FY2025, three months to 2025-03-31654,418 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure310Diluted shares (weighted), Q1 FY2026, three months to 2025-09-30310,309,659 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001213900-25-110299.Report this figure349Diluted shares (weighted), Q2 FY2026, three months to 2025-12-31349,464,317 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-13, accession 0001213900-26-015867.Report this figure12.3Diluted shares (weighted), Q3 FY2026, three months to 2026-03-3112,348,460 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001213900-26-057227.Report this figure

Shares outstanding: 12.54mShares outstanding, period not labelled, at 2026-09-2412,544,627 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-K filed 2026-09-25, accession 0001628280-26-063506.Report this figure at Sep 24, 2026, from the cover of the 10-K filed Sep 25, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.